Fractyl Health Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 73

Employees

  • Stock Symbol
  • GUTS

Stock Symbol

  • Share Price
  • $0.83
  • (As of Friday Closing)

Fractyl Health General Information

Description

Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.

Contact Information

Website
www.fractyl.com
Formerly Known As
MedCatalyst, Fractyl Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 3 Van de Graaff Drive
  • Suite 200
  • Burlington, MA 01803
  • United States
+1 (781)
Primary Industry
Drug Discovery
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 3 Van de Graaff Drive
  • Suite 200
  • Burlington, MA 01803
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fractyl Health Stock Performance

As of 20-Nov-2026, Fractyl Health’s stock price is $0.83. Its current market cap is $10.9M with 13.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.83 $0.96 $0.78 - $29.34 $10.9M 13.3M 502K -$3.11

Fractyl Health Financials Summary

As of 30-Sep-2026, Fractyl Health has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 100,254 286,025 77,351
Revenue 0 0 93 120
EBITDA (75,049) (141,365) (72,163) (78,065)
Net Income (74,197) (140,954) (68,694) (77,091)
Total Assets 65,925 121,402 108,077 76,212
Total Debt 59,533 61,646 62,500 86,391
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Fractyl Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fractyl Health‘s full profile, request access.

Request a free trial

Fractyl Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Fractyl Health‘s full profile, request access.

Request a free trial

Fractyl Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat ob
Drug Discovery
Burlington, MA
73 As of 2025

Stockholm, Sweden
 

Berkeley, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fractyl Health Competitors (22)

One of Fractyl Health’s 22 competitors is Diamyd Medical, a Corporation company based in Stockholm, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Diamyd Medical Corporation Stockholm, Sweden
Carmot Therapeutics Formerly VC-backed Berkeley, CA
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
MannKind Formerly VC-backed Danbury, CT
XBiotech Corporation Austin, TX
You’re viewing 5 of 22 competitors. Get the full list »

Fractyl Health Patents

Fractyl Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260263640-A1 Gene therapy compositions, methods, and systems for weight loss and maintenance Pending 10-Mar-2025
WO-2026192937-A1 Systems, methods, and compositions for weight loss and maintenance Pending 10-Mar-2025
AU-2025206052-A1 Glp-1 gene therapies for metabolic disorders Pending 05-Jan-2024
EP-4837039-A1 Glp-1 gene therapies for metabolic disorders Pending 05-Jan-2024
WO-2025147630-A1 Glp-1 gene therapies for metabolic disorders Inactive 05-Jan-2024 C12N15/86
To view Fractyl Health’s complete patent history, request access »

Fractyl Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fractyl Health ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

39.85 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Fractyl Health’s complete esg history, request access »

Fractyl Health FAQs

  • When was Fractyl Health founded?

    Fractyl Health was founded in 2010.

  • Where is Fractyl Health headquartered?

    Fractyl Health is headquartered in Burlington, MA.

  • What is the size of Fractyl Health?

    Fractyl Health has 73 total employees.

  • What industry is Fractyl Health in?

    Fractyl Health’s primary industry is Drug Discovery.

  • Is Fractyl Health a private or public company?

    Fractyl Health is a Public company.

  • What is Fractyl Health’s stock symbol?

    The ticker symbol for Fractyl Health is GUTS.

  • What is the current stock price of Fractyl Health?

    As of 20-Nov-2026 the stock price of Fractyl Health is $0.83.

  • What is the current market cap of Fractyl Health?

    The current market capitalization of Fractyl Health is $10.9M.

  • Who are Fractyl Health’s competitors?

    Diamyd Medical, Carmot Therapeutics, Dicerna Pharmaceuticals, MannKind, and XBiotech are some of the 22 competitors of Fractyl Health.

  • What is Fractyl Health’s annual earnings per share (EPS)?

    Fractyl Health’s EPS for 12 months was -$3.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process